Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-03-03

Clinical Trial Update: Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV). [Phase 4]

View source ↗

Summary

Phase 4 colorectal cancer trial update describing the pharmacogenomics blood sampling protocol for irinotecan, fluorouracil, and leucovorin; study status is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FLUOROURACIL (Fluorouracil)
  • Irinotecan (Irinotecan)
  • Leucovorin (folinic acid)

Snippet

Sponsor: Pfizer | Conditions: Colorectal Neoplasms | Phase 4 | Status: COMPLETED